https://www.thebodypro.com/category/abacavir-ziagen/tag/croi-conference-on-retroviruses-and-opportunistic-infections
Abacavir (Ziagen)

CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Reducing Risk of Myocardial Infarction in HIV-Positive People Img

Reducing Risk of Myocardial Infarction in HIV-Positive People

This year at CROI 2018 a few studies tried to explore possible mechanisms for the association of increased myocardial infarction risk and abacavir use.

Abacavir Link to Cardiovascular Events in High-Risk Patients Maintained in D:A:D Study Img

Abacavir Link to Cardiovascular Events in High-Risk Patients Maintained in D:A:D Study

A poster at CROI 2014, presented by Caroline Sabin from University College London and colleagues, presented follow-up results from D:A:D since the initial findings in 2008 of a link between abacavir use and risk of myocardial infarction (MI) in peopl...

Promo Image

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

In a poster that was presented on March 2 at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), the U.S. Food and Drug Administration (FDA) reported that it has found no evidence of an association between abacavir (ABC, Zia...

Promo Image

Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed

The recent availability in the United States and Europe of new fixed-dose combinations of the previously approved nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) abacavir/lamivudine (ABC/3TC, Epzicom, Kivexa) and tenofovir/emtricitabin...